ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CLGN CollPlant Biotechnologies Ltd

5.89
0.5299 (9.89%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,873
Bid Price 5.00
Ask Price 5.95
News -
Day High 5.89

Low
4.22

52 Week Range

High
8.90

Day Low 5.42
Share Name Share Symbol Market Stock Type
CollPlant Biotechnologies Ltd CLGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.5299 9.89% 5.89 19:00:00
Open Price Low Price High Price Close Price Previous Close
5.42 5.42 5.89 5.89 5.3601
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
58 5,873 US$ 5.63 US$ 33,037 - 4.22 - 8.90
Last Trade Type Quantity Price Currency
15:00:00 1 US$ 5.86 USD

CollPlant Biotechnologies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
65.91M 11.19M - 10.96M -7.02M -0.63 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CollPlant Biotechnologies News

Date Time Source News Article
4/04/202406:31IH Market NewsUS Index Futures Rise, Oil Dips Slightly
2/15/202407:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202407:00PR Newswire (US)CollPlant Issues Letter to Shareholders
1/25/202414:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/02/202406:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/202306:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202306:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202315:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202306:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
9/21/202306:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202311:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
9/01/202315:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CLGN Message Board. Create One! See More Posts on CLGN Message Board See More Message Board Posts

Historical CLGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.225.895.195.364,8880.6712.84%
1 Month5.405.895.105.264,9310.499.07%
3 Months5.315.894.225.267,0620.5810.92%
6 Months5.176.994.225.4911,5050.7213.93%
1 Year7.108.904.226.1712,474-1.21-17.04%
3 Years14.5823.494.2212.4426,942-8.69-59.60%
5 Years5.225824.263.349912.6628,2370.664212.71%

CollPlant Biotechnologies Description

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

Your Recent History

Delayed Upgrade Clock